Caribou Biosciences, Inc. financial data

Symbol
CRBU on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2929 7 Th Street, Suite 105, Berkeley, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 956 % -2.42%
Debt-to-equity 19.4 % -14%
Return On Equity -45.5 % -49.8%
Return On Assets -38.1 % -53.8%
Operating Margin -1.44K % -356%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 90.6M shares +2.4%
Common Stock, Shares, Outstanding 90.6M shares +2.4%
Entity Public Float 263M USD -14.6%
Common Stock, Value, Issued 9K USD +12.5%
Weighted Average Number of Shares Outstanding, Basic 90.5M shares +7.96%
Weighted Average Number of Shares Outstanding, Diluted 90.5M shares +7.96%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 11.5M USD -66.8%
Research and Development Expense 131M USD +22.9%
General and Administrative Expense 45.7M USD +22.6%
Operating Income (Loss) -165M USD -51.3%
Nonoperating Income (Expense) 17.3M USD +17.3%
Income Tax Expense (Benefit) 193K USD +176%
Net Income (Loss) Attributable to Parent -148M USD -56.7%
Earnings Per Share, Basic -1.58 USD/shares -5.33%
Earnings Per Share, Diluted -1.58 USD/shares -5.33%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 32M USD -69.3%
Marketable Securities, Current 228M USD
Cash, Cash Equivalents, and Short-term Investments 281M USD -29.2%
Accounts Receivable, after Allowance for Credit Loss, Current 184K USD -83.8%
Assets, Current 237M USD -32.3%
Property, Plant and Equipment, Net 19.6M USD +17.9%
Operating Lease, Right-of-Use Asset 20.5M USD -9.64%
Other Assets, Noncurrent 4.74M USD +202%
Assets 344M USD -24.7%
Accounts Payable, Current 2.7M USD +13.8%
Employee-related Liabilities, Current 7.09M USD +5.97%
Accrued Liabilities, Current 25.4M USD +39.6%
Contract with Customer, Liability, Current 2.83M USD +0.11%
Liabilities, Current 32.2M USD +30.9%
Contract with Customer, Liability, Noncurrent 3.95M USD -41.3%
Deferred Income Tax Liabilities, Net 557K USD +46.2%
Operating Lease, Liability, Noncurrent 25.5M USD -3.24%
Liabilities 63.1M USD +6.55%
Accumulated Other Comprehensive Income (Loss), Net of Tax 789K USD
Retained Earnings (Accumulated Deficit) -413M USD -55.9%
Stockholders' Equity Attributable to Parent 281M USD -29.4%
Liabilities and Equity 344M USD -24.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -37.2M USD -33.2%
Net Cash Provided by (Used in) Financing Activities 12.5M USD +660%
Net Cash Provided by (Used in) Investing Activities 23M USD +10.9%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 90.6M shares +2.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.76M USD +68.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 32M USD -69.2%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 96.2M USD +44.8%
Deferred Tax Assets, Gross 105M USD +36.4%
Operating Lease, Liability 26.6M USD -2.97%
Payments to Acquire Property, Plant, and Equipment 1.45M USD -28.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -146M USD -56.5%
Lessee, Operating Lease, Liability, to be Paid 39M USD -9.07%
Property, Plant and Equipment, Gross 31.4M USD +25.5%
Operating Lease, Liability, Current 1.18M USD +3.42%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.72M USD +27.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.41M USD +13.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.3M USD -20%
Lessee, Operating Lease, Liability, to be Paid, Year Three 5.92M USD +3.53%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 4.09M USD +46.2%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.12M USD +3.38%
Operating Lease, Payments 711K USD -35%
Additional Paid in Capital 693M USD +4.41%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 710K USD +20.5%
Deferred Tax Assets, Net of Valuation Allowance 8.76M USD -16.6%
Share-based Payment Arrangement, Expense 16.4M USD +23%
Interest Expense 4K USD -100%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%